13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001442756
Total reported value
$1.2B
$1.2B
65 檔
42.2%
According to the latest 13F quarterly dataset, PFM Health Sciences, LP managed an equity portfolio of $1.2B at the end of Q1 2025, spanning 65 distinct U.S. exchange-listed positions.
In Q1 2025, PFM Health Sciences, LP adopted a defensive or profit-taking posture, trimming 17 positions and completely liquidating 59 holdings to manage risk exposure.
In terms of portfolio concentration, the top 5 core holdings (including LLY, ABBV, THC) accounted for 42.2% of total reported equity market value during Q1 2025.
Top New Position Initiated
AXSM
市值: $64.9M
Top Position Liquidated / Trimmed
ALXN
前期市值: $165.6M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | Stock-Healthcare | 16.42% | -1.48% | -8.33% | |
| 2 | ABBV | Abbvie Inc | Stock-Healthcare | 5.05% | — | — | |
| 3 | THC | Tenet Healthcare CORP | Stock-Healthcare | 4.80% | -4.83% | — | |
| 4 | MCK | Mckesson CORP | Stock-Healthcare | 4.76% | — | — | |
| 5 | AXSM | Axsome Therapeutics Inc | Stock-Healthcare | 4.71% | +0.54% | +19.07% | |
| 6 | XLV | Ss Health Care Select Sector | ETF-Other | 4.56% | -3.19% | EXIT | |
| 7 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 4.47% | — | — | |
| 8 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 3.35% | — | — | |
| 9 | PEN | Penumbra Inc | Stock-Healthcare | 3.23% | -2.56% | — | |
| 10 | SLNOEUR | Soleno Therapeutics Inc | Stock-Other | 3.09% | -0.76% | EXIT | |
| 11 | ARGX | Argenx Se - Adr | Stock-Healthcare | 2.97% | +0.06% | +8.32% | |
| 12 | ELV | Elevance Health Inc | Stock-Healthcare | 2.79% | — | — | |
| 13 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | 2.28% | -0.13% | +166.91% | |
| 14 | UHS | Universal Health Services-b | Stock-Healthcare | 2.12% | — | -27.32% | |
| 15 | ASND | Ascendis Pharma A/S | Stock-Other | 2.12% | -3.64% | EXIT | |
| 16 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 2.00% | +0.08% | -66.06% | |
| 17 | ASND 2.25 04-01-28Bond | Ascendis Pharma A/s | Bond | 1.99% | -1.54% | EXIT | |
| 18 | HCA | Hca Healthcare Inc | Stock-Healthcare | 1.94% | -0.49% | +11.55% | |
| 19 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 1.71% | — | — | |
| 20 | MOH | Molina Healthcare Inc | Stock-Healthcare | 1.68% | — | — | |
| 21 | DHR | Danaher CORP | Stock-Healthcare | 1.67% | — | -10.39% | |
| 22 | CVS | Cvs Health CORP | Stock-Healthcare | 1.54% | +1.22% | NEW | |
| 23 | BDX | Becton Dickinson And Co | Stock-Healthcare | 1.52% | — | — | |
| 24 | IQV | Iqvia Holdings Inc | Stock-Healthcare | 1.43% | — | — | |
| 25 | WAT | Waters CORP | Stock-Healthcare | 1.39% | +0.85% | -12.18% | |
| 26 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 1.37% | +1.72% | -72.98% | |
| 27 | OM | Outset Medical Inc | Stock-Other | 1.35% | +0.01% | — | |
| 28 | HUM | Humana Inc | Stock-Healthcare | 1.21% | +3.22% | NEW | |
| 29 | XRT | Ss Spdr S&p Retail ETF | ETF-Other | 0.97% | — | — | |
| 30 | SNDX | Syndax Pharmaceuticals Inc | Stock-Other | 0.83% | -0.30% | +347.83% | |
| 31 | OSCR | Oscar Health Inc - Class A | Stock-Healthcare | 0.82% | +0.75% | — | |
| 32 | INDV | Indivior Pharmaceuticals, Inc. | Stock-Other | 0.80% | — | — | |
| 33 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 0.80% | — | — | |
| 34 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 0.79% | +0.57% | +4.07% | |
| 35 | SRPT 1.25 09-15-27Bond | Sarepta Therapeutics Inc | Bond | 0.68% | — | +29.03% | |
| 36 | CNC | Centene CORP | Stock-Healthcare | 0.60% | +1.07% | -6.30% | |
| 37 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 0.60% | -1.91% | EXIT | |
| 38 | ICLR | ICON Public Limited Company | Stock-Healthcare | 0.52% | +1.45% | -68.10% | |
| 39 | QURE | uniQure N.V. | Stock-Other | 0.46% | +0.04% | +111.88% | |
| 40 | INBX | Inhibrx Biosciences Inc | Stock-Other | 0.45% | +0.64% | +224.08% | |
| 41 | PRAX | Praxis Precision Medicines I | Stock-Other | 0.44% | +0.07% | +34.61% | |
| 42 | NEO | Neogenomics Inc | Stock-Healthcare | 0.40% | -1.21% | EXIT | |
| 43 | ERAS | Erasca Inc | Stock-Other | 0.35% | +0.21% | NEW | |
| 44 | BHVN | Biohaven Ltd. | Stock-Other | 0.34% | — | -54.32% | |
| 45 | 2655787D | Blueprint Medicines CORP | Stock-Other | 0.30% | — | +8.43% | |
| 46 | PMVP | Pmv Pharmaceuticals Inc | Stock-Other | 0.26% | — | +58.80% | |
| 47 | SRPT | Sarepta Therapeutics Inc | Stock-Healthcare | 0.24% | — | -49.28% | |
| 48 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 0.22% | — | -21.16% | |
| 49 | AMLX | Amylyx Pharmaceuticals Inc | Stock-Other | 0.21% | +0.04% | — | |
| 50 | IOBTQ | Io Biotech Inc | Stock-Other | 0.19% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | +12.6% | -8.33% | Trim |
| 2 | THC | Tenet Healthcare CORP | +3.4% | — | Trim |
| 3 | MCK | Mckesson CORP | +2.6% | — | Trim |
| 4 | PEN | Penumbra Inc | +2.1% | — | Add |
| 5 | ABBV | Abbvie Inc | +1.8% | — | Trim |
| 6 | MOH | Molina Healthcare Inc | +1.1% | — | Unchanged |
| 7 | AZNN | Astrazeneca Plc-spons Adr | +0.4% | — | Trim |
| 8 | EW | Edwards Lifesciences CORP | +0.3% | -66.06% | Trim |
| 9 | TMO | Thermo Fisher Scientific Inc | +0.2% | +4.07% | Trim |
| 10 | DHR | Danaher CORP | +0.2% | -10.39% | Trim |
| 11 | WAT | Waters CORP | +0.1% | -12.18% | Trim |
| 12 | HOWL | Werewolf Therapeutics Inc | 0% | -13.73% | Add |
| 13 | PMVP | Pmv Pharmaceuticals Inc | -0.1% | +58.80% | Add |
| 14 | UHS | Universal Health Services-b | -0.1% | -27.32% | Trim |
| 15 | SNDX | Syndax Pharmaceuticals Inc | -0.3% | +347.83% | Trim |
| 16 | ICLR | ICON Public Limited Company | -0.4% | -68.10% | Trim |
| 17 | UNH | Unitedhealth Group Inc | -0.5% | -72.98% | Trim |
| 18 | HCA | Hca Healthcare Inc | -0.6% | +11.55% | Trim |
| 19 | HUM | Humana Inc | -0.8% | -23.84% | Trim |
| 20 | IQV | Iqvia Holdings Inc | -1.3% | — | Trim |
| 21 | CNC | Centene CORP | -2.3% | -6.30% | Trim |
| 22 | ALXN | Alexion Pharmaceuticals Inc | — | EXIT | Sold out |
| 23 | ✓ | Horizon Therapeutics PLC | — | EXIT | Sold out |
| 24 | OMGBP | Outset Medical Inc | — | EXIT | Sold out |
| 25 | NBIX | Neurocrine Biosciences Inc | — | EXIT | Sold out |
| 26 | RCUS | Arcus Biosciences Inc | — | EXIT | Sold out |
| 27 | MYGN | Myriad Genetics Inc | — | EXIT | Sold out |
| 28 | ACAD | Acadia Pharmaceuticals Inc | — | EXIT | Sold out |
| 29 | SGENUSD | Seagen Inc | — | EXIT | Sold out |
| 30 | AVTR | Avantor Inc | — | EXIT | Sold out |
| 31 | NVROEUR | Nevro CORP | — | EXIT | Sold out |
| 32 | AXSM | Axsome Therapeutics Inc | — | NEW | New buy |
| 33 | XLV | Ss Health Care Select Sector | — | NEW | New buy |
| 34 | VRTX | Vertex Pharmaceuticals Inc | — | NEW | New buy |
| 35 | ICUI | Icu Medical Inc | — | EXIT | Sold out |
| 36 | AERI 1.5 10-01-24Bond | Aerie Pharmaceuticals | — | EXIT | Sold out |
| 37 | BMRN 0.599 08-01-24Bond | Biomarin Pharmaceutical | — | EXIT | Sold out |
| 38 | GH | Guardant Health Inc | — | EXIT | Sold out |
| 39 | MRTXEUR | Mirati Therapeutics Inc | — | EXIT | Sold out |
| 40 | ISRG | Intuitive Surgical Inc | — | NEW | New buy |
| 41 | GILD | Gilead Sciences Inc | — | EXIT | Sold out |
| 42 | BIIB | Biogen Inc | — | EXIT | Sold out |
| 43 | ✓ | Myovant Sciences LTD | — | EXIT | Sold out |
| 44 | NTLA | Intellia Therapeutics Inc | — | EXIT | Sold out |
| 45 | SLNOEUR | Soleno Therapeutics Inc | — | NEW | New buy |
| 46 | ARGX | Argenx Se - Adr | — | NEW | New buy |
| 47 | CYTK | Cytokinetics Inc | — | EXIT | Sold out |
| 48 | ELV | Elevance Health Inc | — | NEW | New buy |
| 49 | BAX | Baxter International Inc | — | EXIT | Sold out |
| 50 | AERIEUR | Aerie Pharmaceuticals Inc | — | EXIT | Sold out |
According to official SEC Form 13F filings, PFM Health Sciences, LP reported a total U.S. public equity portfolio value of $1.2B across 65 disclosed positions in Q1 2025.
During Q1 2025, PFM Health Sciences, LP's top holdings by market value included LLY (16.4%)、ABBV (5.0%)、THC (4.8%). The largest single position, LLY, represented 16.4% of total portfolio value.
In Q1 2025, PFM Health Sciences, LP made 123 total portfolio adjustments, initiating 44 new buys, adding to 3 positions, trimming 17 holdings, and fully liquidating 59 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.